Second Half Financial Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$572K Buy
477
+155
+48% +$158K 0.23% 57
2026
Q1
$296K Sell
322
-10
-3% -$10.1K 0.13% 71
2025
Q4
$356K Sell
332
-12
-3% -$11.5K 0.16% 57
2025
Q3
$262K Buy
+344
New +$256K 0.12% 78
2024
Q4
Sell
-237
Closed -$210K 104
2024
Q3
$210K Buy
+237
New +$213K 0.11% 90
2023
Q1
Sell
-9,867
Closed -$3.4M 41
2022
Q4
$3.4M Sell
9,867
-103
-1% -$36.5K 2.21% 15
2022
Q3
$3.22M Buy
+9,970
New +$3.16M 4.01% 10

Other funds holding LLY

Second Half Financial Partners's LLY Position: Q2 2026 in Review

Second Half Financial Partners increased its Eli Lilly (LLY) stake by 48% in Q2 2026, buying an estimated $158K and bringing the position to 477 shares worth $572K. The position accounts for 0.23% of the portfolio, ranked #57.

Second Half Financial Partners first reported a position in LLY in Q3 2022 and has held it in 7 quarters since. The position peaked at $3.4M in Q4 2022. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Second Half Financial Partners held 477 shares of Eli Lilly worth $572K as of Q2 2026.
  • Second Half Financial Partners bought 155 Eli Lilly shares in Q2 2026, an estimated $158K.
  • Eli Lilly made up 0.23% of Second Half Financial Partners's portfolio in Q2 2026, its #57 holding.
  • Second Half Financial Partners first reported a position in Eli Lilly in Q3 2022 and has held it in 7 quarters since.
  • Second Half Financial Partners's Eli Lilly position peaked at $3.4M in Q4 2022.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Second Half Financial Partners's 13F filing for Q2 2026, filed 17 Jul 2026.